Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales

Table 4 Correlations between examined parameters in examined alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients

Pair	R Spearman	P value
ALC
MPR and APRI	0.691	c
MPR and FIB-4	0.776	c
NLR and AAR	0.173	a
NLR and GPR	0.183	a
PLR and APRI	-0.535	c
PLR and FIB-4	-0.557	c
MPR and MELD	0.343	d
NLR and MELD	0.379	d
PLR and MELD	-0.235	b
NLR and PIIINP	-0.183	a
MPR and PDGF-AB	-0.366	c
PLR and PDGF-AB	0.272	b
NAFLD
MPR and APRI	0.557	d
MPR and FIB-4	0.603	d
MPR and GPR	0.303	b
MPR and NFS	0.587	d

^aP < 0.05.

^bP < 0.01.

^cP < 0.001.

^dP < 0.0001. ALC: Alcoholic liver cirrhosis; NAFLD: Nonalcoholic fatty liver disease; NLR: Neutrophil-to-lymphocyte ratio; PLR: Platelet-to-lymphocyte ratio; MPR: Mean platelet volume-to-platelet-ratio; AAR: Aspartate transaminase to alkaline transaminase ratio; APRI: Aspartate transaminase to platelet ratio index; FIB-4: Fibrosis-4; GPR: Gamma-glutamyl transpeptidase to platelet ratio; PICP: Procollagen I carboxyterminal propeptide; PIIINP: Procollagen III aminoterminal propeptide; PDGF-AB: Platelet-derived growth factor AB.